Cited by 442Gut microbiota and healthLiver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier

Open access

Zhou, Da, Pan, Qin, Xin, Feng-Zhi, Zhang, Rui-Nan, He, Chong-Xin, Chen, Guang-Yu, Liu, Chang, Chen, Yuan-Wen, Fan, Jian-Gao·2017·World Journal of Gastroenterology

DOI 10.3748/wjg.v23.i1.60PMC PMC5221287

Open this paper in CoChat — free account

Abstract

AIM: To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS: Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation- or metabolism-associated genes were quantified by real-time PCR. RESULTS: . These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-α, IL-1, IL-2, IL-6 and IFN-γ in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION: NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.

Integrity signals

Registry

Crossref · 10.3748/wjg.v23.i1.60

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164

Show all 56 references

Sorted by citations

Items 401–442 of 442

The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease
Сергеевна, К. Т., Livzan, M. A., & Syrovenko, M. I. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-009
The Role of the Intestinal Microbiota in NAFLD Onset and Progression
Pinheiro, I. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007741
Gut Microbiota Mechanism of Fetal-Originated Disease
Wang, H., Lu, X., & Ma, C. (2024) · Springer eBooks · doi:10.1007/978-981-97-5730-5_6
Meta-analysis of postbiotics on evaluating health benefits and mechanisms
Barathikannan, K., Chelliah, R., David, H. A., Kulandairaj, E. P., Vijayalakshmi, S., Rubab, M., & Oh, D.-H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22188-0.00019-x
Development Of a Gc-Ms Method for Urinary Short-Chain Fatty Acids Quantification: Differences and Potential Indicators in Nafld and Healthy IndividualsPreprint
Xie, J., Zhou, R., Yang, Y., Du, X., Wang, J., Kong, L., Wu, L., Wu, Y., Meng, Y., & Gao, R. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5245700
The Causal Relationship between Gut Microbiota and Oral Lichen Planus: Insights from Mendelian Randomization Studies
符, 兴. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551433
Inulin and its Effect on Inflammation Markers: A Literature Review
Raygoza, N. P., Flores-Vargas, G., López-Guzmán, O., & Rodríguez-Aguilar, Y. V. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3159
Phenotypes of non-alcoholic fatty liver disease in people with normal and increased body mass: issues of epidemiology and etiology, clinical and pathogenetic features and diagnostic approaches. Literature review
Shevlyukova, T. P., Bulatova, I. A., Vladimirskiy, V. E., Смирнова, E. N., Trofimova, E. S., & Yusupova, A. A. (2025) · Perm Medical Journal · doi:10.17816/pmj42420-40
Nutritional significance of short-chain fatty acids
Karadağ, M. G., Tuğ, T. A., Ağagündüz, D., & Özoğul, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33296-8.00005-8
Additional file 1 of Coated sodium butyrate ameliorates high-energy and low-protein diet induced hepatic dysfunction via modulating mitochondrial dynamics, autophagy and apoptosis in laying hens
Miao, S., Mu, T., Li, R., Li, Y., Zhao, W., Li, J., Dong, X., & Zou, X. (2024) · Figshare · doi:10.6084/m9.figshare.26673975
Additional file 1 of Enzymatically prepared alginate oligosaccharides improve broiler chicken growth performance by modulating the gut microbiota and growth hormone signals
Zhu La, A. L. T., Feng, Y., Hu, D., Feng, Y., Jin, X., Liu, D., Guo, Y., Cheng, G., & Hu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26597357
Additional file 1 of Dietary sodium acetate and sodium butyrate improve high-carbohydrate diet utilization by regulating gut microbiota, liver lipid metabolism, oxidative stress, and inflammation in largemouth bass (Micropterus salmoides)
Liu, Q., Cheng, L., Wang, M., Shen, L., Zhang, C., Mu, J., Hu, Y., Yang, Y., He, K., Yan, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26694636
Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption?
Giannitrapani, L., Ferraro, M., Seidita, A., Licata, A., & Soresi, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i12.110076
Marine Algal Polysaccharides in the Management of Liver Disease
Qeshmi, F. I., Ghattavi, S., & Homaei, A. A. (2026) · Springer eBooks · doi:10.1007/978-981-95-4126-3_8
Nicotinamide Mononucleotide Modulates Endothelin-1 via NR4A1 and Histone Modifications in Canine Intestinal Epithelial Cells
Guo, X., Zhu, C., Adam, S. Y., Zhu, C., Liu, H., & Cai, D. (2026) · Animals · doi:10.3390/ani16040591
Gut bacteriome alterations during high altitude exposure: a comprehensive analysis of different species
Yin, X., Zeng, J., Li, Z., Chen, S., Xie, C., Li, X., Zhang, L., Pan, Y., & An, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1762563 · Cited by 1
INU/AOS attenuates DEX-induced osteoporosis via interacting with gut microbiota and reversing inflammation in mice
(6520), L. Y., Liao, R., Hu, X., Hu, L., Li, S., Liu, Y., Zeng, Z., Li, R., Fang, Z., & Chen, H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108584
Epigenetic influences of the gut microbiome: a new frontier in medicine
Naseer, F., Khan, H., Rehman, B., Ahmad, P., Tariq, F., & Rauf, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00011-x
Effects of U62631.5 on short-chain fatty acid receptor 41(GPR41) and the related intestinal bacterium Butyricicoccus pullicaecorum after fecal bacterial transplantation in nonalcoholic fatty liver disease
Hao, X., Ma, C., Gao, X., Wang, F., Han, B., Bai, D. G., Ou, L., & Zeng, Q. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05014-7
Étude des effets des acides gras oméga-3 et de nouvelles bactéries probiotiques pour contrer les désordres associés à l'obésité au niveau métabolique et intestinal
Barz, M. L. (2017) · theses.fr (ABES) · doi:10.70675/d1f0a7a2z6eadz445dzb191za197a6f08824
Differentiation and activation of Peyer’s patch phagocytes in adulthood and upon weaning
Wagner, C. (2020) · theses.fr (ABES) · doi:10.70675/c0f7e7aazfdf6z474dz826bz26f9444d5035
Rôle du récepteur nucléaire Farnesoid X Receptor intestinal dans la fonction immune de l’intestin dans le contexte physiopathologique de la stéatohépatite non alcoolique
Nawrot, M. (2021) · theses.fr (ABES) · doi:10.70675/93b65019zae01z425eza715z4de3ea0a3be8
L'utilisation de Lactococcus lactis recombinant promouvant l'expression de peptides antimicrobiens pour le traitement de l'inflammation dans l'intestin : Interactions hôte-microbiote
Nogués, E. B. (2022) · theses.fr (ABES) · doi:10.70675/afb0eb10z26acz4c84z9eefz36086c870850
Oroxin A in Linggui Zhugan Decoction in the treatment of MASH by regulating cholesterol-bile acid metabolism
Gao, P., Wang, S., Jia, M., Jingke, M., Jia, B., Chen, Y., Xing, Q., Wang, W., Zhang, Y., & Chai, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121684
Self-citation
Influence of blood-brain barrier and intestinal barrier on microglial phenotypes: a perspective of clinical and prognostic implications
Lima, M. N., Santos, L. F., Lemos, F. S., Reis, P. A., Maron‐Gutierrez, T., & Castro-Faria-Neto, H. C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1663796
A Novel Synbiotics-Lactobacillus -ML/MN/T2/T23/TF from Ethanol-Tolerant Healthy Individuals in Combination with Sodium Butyrate Alleviates Alcoholic Liver Disease by Restoring the Homeostasis of Gut-Liver AxisPreprint
Long, F., Li, J., Kang, Y., Li, Y. Q., Ma, T., Ma, J. J., Liu, J., Yang, P., Luo, S., Zhang, L. P., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9739470/v1
Yinchen Wuling San ameliorates high-fat diet-induced metabolic-associated fatty liver disease in rats by remodeling the gut microbiota
ZHANG, Y. Z., Liu, J., Huang, A.-S., Wang, Y.-F., Cao, J., Li, M.-L., Shi, D.-D., Hu, Y.-L., Deng, Q., Long, P., et al. (2026) · World Journal of Hepatology · doi:10.4254/wjh.118607
Sinensetin ameliorates established high-fat diet-induced liver injury and intestinal barrier dysfunction through the mitophagy/TLR4/MAPK signaling pathway
Meng, Z., Zhang, Q., Zhao, Z., Zhang, Y., Lu, Z., Liu, G., Xiang, W., Zhang, Q., & Tang, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1812651
Butyrate ameliorates maternal high-fat-diet-induced placental inflammation and offspring metabolic dysfunction via modulating gut microbiota in mice
Xu, Y., Zhang, Q., Lu, X., Ji, P., He, Z., Wang, Y., & Dong, Y. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04018-3
Intestinal Lactobacillus: Origins, colonization factors, diversity, and health associations
Liu, J., Luo, M., Li, B., Xia, X., & Huang, L. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108681
Gut‐Derived Sodium Butyrate Attenuates Liver Fibrosis by Inhibiting Aerobic Glycolysis via the HDAC3/c‐Myc Signaling Axis
Sun, Y., Wu, H.-Y., Zhou, Y.-T., Yin, P., Wu, L., Li, H., Zuo, S., Yang, Z., & Cao, K. (2026) · The FASEB Journal · doi:10.1096/fj.202504713r
Microbiome‐Derived Metabolite Networks in Metabolic Dysfunction‐Associated Fatty Liver Disease: Mechanistic Integration of Gut‐Liver Axis Signaling and Therapeutic Targeting
Muniraj, A., Elango, S. V., Iyer, M., Rani, M. R., Vinayagam, S., Gnanasekaran, L., Yadav, M. K., Rao, K. R. S. S., Vellingiri, B., Mukherjee, A. G., et al. (2026) · Comprehensive physiology · doi:10.1002/cph4.70220 · Cited by 1
Assessment of gastrointestinal changes in acute pancreatitis: Advances in imaging and clinical research
Tang, C.-H., Meng-Ting, Z., Zhong, X.-Y., Zhang, T., & Zhang, X.-M. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i6.465
Sophora moorcroftiana Seeds Ethanol Extract Against Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice by Modulating Gut Microbiota Dysbiosis, SCFAs, and Related Inflammation
Chu, X., Zhang, S., Cui, M., Sun, X., Chen, X., Gao, L., Yuan, R., Wang, S., Huang, S., & Li, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167368
Potential mechanisms by which microbiota-accessible carbohydrates regulate hepatic lipid metabolism in MAFLD via the gut-liver axis
Peng, J., Gao, X., Chen, G., Yan, A., Yu, Q., Tian, W., & Cai, K. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1898227
Self-citation
Sodium butyrate protects broiler chickens against lethal Salmonella Enteritidis infection by remodelling the gut microbiota and preserving immune homeostasis
He, J., Xie, C., Jinglan, L. U., Yu, J., Lai, L., Chen, P., Shu, D., & Ji, J. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107683
Microbiome and Diseases: Metabolic Disorders
Clavel, T., & Ecker, J. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_16
Alkole Bağlı Olmayan Yağlı Karaciğer Hastalığı Patogenezinde Mikrobiyotanın ve Risk Faktörlerinin Rolü: Güncel Bulgular ve Tedavi Stratejileri
Erkmen, O., & Karaağaç, R. M. (2026) · Bilecik Şeyh Edebali Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.61535/bseusbfd.1586024
Sodium butyrate combined with ethanol-metabolizing Lactobacillus strains attenuates alcoholic liver disease by restoring gut-liver homeostasis
Long, F., Li, J., Kang, Y., Li, Y., Ma, T., Ma, J., Liu, J., Yang, P., Luo, S., Zhang, L., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179394
Faecalibacterium prausnitzii: Mechanistic Insights and Therapeutic Potential in Host–Microbe Crosstalk
Qin, W., Wang, G., Fu, Y., Zeng, Y., Xia, Y., Sheng, Y., & Ai, L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11236-y
Dietary butyrate alleviates high-fat diet-induced colonic mucosal impairment accompanied by increased gut-derived indole-3-acetic acid and enhanced PPARγ signaling
Li, G., Dong, S., Liu, C., Yan, H., Yang, J., Rensen, P. C. N., Shi, B., & Wang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1971187
Self-citation
BindingDB Entry 50002065: Structural Modification of Natural Product Ganomycin I Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo.
BindingDB (2020) · UC San Diego · doi:10.7270/q2zs3045

Authors: Zhou, D., Pan, Q., Xin, F.-Z., Zhang, R.-N., He, C.-X., Chen, G.-Y., Liu, C., Chen, Y.-W., & Fan, J.-G.
Affiliations: Shanghai Jiao Tong University (CN)
ORCID: Zhou, Da
Pan, Qin
Zhang, Rui-Nan
Liu, Chang
Fan, Jian-Gao
Venue: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Published: 2017
Volume: 23
Issue: 1
Pages: 60
ISSN: 1007-9327 (ISSN-L)
DOI: 10.3748/wjg.v23.i1.60
PMC: PMC5221287
OpenAlex: W2571212804
Cited by: 441
References: 56
Citations by year: 2026: 34 · 2025: 61 · 2024: 66 · 2023: 58 · 2022: 68 · 2021: 46 · 2020: 50 · 2019: 30 · 2018: 17 · 2017: 11
FWCI: 12.17
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: World Journal of Gastroenterology (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords: sodium butyrate, non-alcoholic fatty liver disease, steatohepatitis, high-fat diet, gut microbiota, intestinal barrier, zonula occludens-1, endotoxin, gut-liver axis, gut dysbiosis, inflammation, insulin resistance, butyrate
MeSH terms: Gastrointestinal Microbiome, Animals, Drug Evaluation, Preclinical, Humans, Immunohistochemistry, Inflammation, Intestinal Mucosa, Lactobacillus, Liver, Liver Function Tests, Male, Mice, Inbred C57BL, Specific Pathogen-Free Organisms, Tumor Necrosis Factor-alpha, Cytokines, Butyric Acid, Mice, Diet, High-Fat, Real-Time Polymerase Chain Reaction, Zonula Occludens-1 Protein, Dysbiosis, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks